dc.creator | Appenzeller S. | |
dc.creator | Costallat L.T.L. | |
dc.date | 2004 | |
dc.date | 2015-06-26T14:24:02Z | |
dc.date | 2015-11-26T14:12:47Z | |
dc.date | 2015-06-26T14:24:02Z | |
dc.date | 2015-11-26T14:12:47Z | |
dc.date.accessioned | 2018-03-28T21:13:28Z | |
dc.date.available | 2018-03-28T21:13:28Z | |
dc.identifier | | |
dc.identifier | Revista Brasileira De Reumatologia. , v. 44, n. 3, p. 198 - 205, 2004. | |
dc.identifier | 4825004 | |
dc.identifier | | |
dc.identifier | http://www.scopus.com/inward/record.url?eid=2-s2.0-77956681651&partnerID=40&md5=d087217215fd1ff608c8c4befd1d884b | |
dc.identifier | http://www.repositorio.unicamp.br/handle/REPOSIP/94328 | |
dc.identifier | http://repositorio.unicamp.br/jspui/handle/REPOSIP/94328 | |
dc.identifier | 2-s2.0-77956681651 | |
dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/1242101 | |
dc.description | Epidemiological studies using multivariate analysis of risk factors in Systemic Lupus Erythematosus (SLE) patients are essential to determinate survival and to demonstrate diagnosis and treatment strategies. Objective: To analyse the risk factors of mortality in 509 SLE patients who were followed over a 27-year period (from 1974 to 2001) according to a standard protocol in a single centre. The first analysis consisted of the survival time from the date of diagnosis of SLE until the last contact or death. The second analysis consisted of the survival time from the date of diagnosis of SLE until the last contact or death of patients whose disease started before 16 years old compared to patients whose disease started after 16 years old. Methods: The percentage of survival after 1, 5, 10 and 20 years were 96%, 88%, 80% and 75%. The risk factors for death in SLE patients were the absence of arthritis at diagnosis (p = 0.007; OR = 0.45; 95% IC = 0.25-0.8), the absence of chloroquine sulphate prescription (p = 0.0001; OR = 0.3; 95% CI = 0.2-0.5), the presence of hypertension (p = 0.002; OR = 2.2; 95% CI = 1.1-4.5), the presence of infections (p = 0.003; OR = 2.3; 95% CI = 1.3-4.1) and less than 16 years old at diagnosis (p = 0.004; OR = 2.6; 95% CI = 1.4-5.0). Conclusions: This paper presents an excellent survival in this cohort of 509 SLE patients. The percentage of survival after 1, 5, 10 and 20 years, respectively 96%, 88%, 80% and 75%, was similar to other studies. | |
dc.description | 44 | |
dc.description | 3 | |
dc.description | 198 | |
dc.description | 205 | |
dc.description | Carbotte, R.M., Denburg, S.D., Denburg, J.A., Prevalence of cognitive impairment in systemic lupus erythematosus (1986) J Nerv Ment Dis, 174, pp. 357-364 | |
dc.description | Harvey, A.M., Systemic Lupus erythematosus: Review of literature and clinical analysis of 138 cases (1954) Medicine, 33, pp. 291-437 | |
dc.description | Merrel, M., Shulman, E., Determination of prognosis in chronic disease, illustred by lupus erythematosus (1955) J. Chronic Dis, 1, pp. 12-32 | |
dc.description | Ganczareczyk, L., Urowitz, M.B., Gladman, D.D., Latent Lupus (1989) J Rheumatol, 16, pp. 475-478 | |
dc.description | Abu-Shakra, M., Urowitz, M.B., Gladman, D.D., Gough, J., Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death (1995) J Rheumatol, 22, pp. 1259-1264 | |
dc.description | Gripenberg, M., Helve, T., Outcome of systemic lupus erythematosus. A study of 66 patients over 7 years with special reference to the predictive value of anti DNA determination (1991) Scand J Rheumatol, 20, pp. 104-109 | |
dc.description | Pistiner, M., Wallace, D.J., Nessim, S., Metzger, A.L., Klinenberg, J.R., Lupus erythematosus in the 1980s: A survey of 570 patients (1991) Semin Arthritis Rheum, 21, pp. 55-64 | |
dc.description | Reveille, J.D., Bartolucci, A., Alarcon, G.S., Prognosis in SLE: Negative impact of increasing age in onset, black race and thrombocytopenia, as well as causes of death (1990) Arthritis Rheum, 33, pp. 37-48 | |
dc.description | Gladmann, D.D., Prognosis of systemic lupus erythematosus and factors that affect it (1992) Curr Opin Rheumatol, 4, pp. 681-687 | |
dc.description | Sato, E.I., Vieira, A.L., Porchini, A.C., Fatores prognósticos no lúpus eritematoso sistêmico (1995) Rev Bras Reumatol, 35, pp. 235-241 | |
dc.description | Sibley, J.T., Olszynski, W.P., Decoteau, W.E., Sundaram, M.B., The incidence and prognosis of central nervous system disease in SLE (1992) J Rheumatol, 19, pp. 47-52 | |
dc.description | Hellmann, D.B., Fatal infection in systemic lupus erythematosus: The role of opportunistic organisms (1987) Medicine, 66, pp. 341-348 | |
dc.description | Tan, E.M., Cohen, A.S., Fries, J.F., The 1982 revised criteria for the classification of systemic lupus erythematosus (1982) Arthritis Rheum, 25, pp. 1271-1277 | |
dc.description | Kaplan, E.L., Meier, P., Nonparametric estimation from incomplete observations (1953) J AM Sat Assoc, 53, pp. 457-481 | |
dc.description | Cox, D.R., Regression models and life tables (1972) J R Stat Soc, 34, pp. 187-202 | |
dc.description | Fries, J.F., Weyl, S., Holman, H.R., Estimating prognosis in systemic lupus erythematosus (1974) Am J Med, 57, pp. 561-565 | |
dc.description | Seleznick, M.J., Fries, J.F., Variables associated with decreased survival in SLE (1991) Semin Arthrits Rheum, 21, pp. 73-80 | |
dc.description | Kaufman, L.D., Gomez-Reino, J.J., Heinicke, M.H., Gorevic, P.D., Male lupus: Retrospective analysis of the clinical and laboratory features of 52 patients, with a review of the literature (1989) Semin Arthritis Rheum, 18, pp. 189-197 | |
dc.description | Schaller, J., Lupus in childhood (1982) Clin Rheumatol, 8, pp. 219-250 | |
dc.description | Tucker, L.B., Menon, S., Schaller, J.G., Isenberg, D.A., Adult and childhood-onset SLE: A comparison of onset, clinical features, serology and outcome (1995) Br J Rheumatol, 34, pp. 866-872 | |
dc.description | Costallat, L.T.L., Coimbra, A.M.V., SLE: Clinical and laboratory aspects related to age at disease (1994) Clin Exp Rheumatol, 12, pp. 603-607 | |
dc.description | Abu-Shakra, M., Urowitz, M.B., Gladman, D.D., Gough, J., Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality (1995) J Rheumatol, 22, pp. 1265-1270 | |
dc.description | Rothfield, N.F., Cardiopulmonar manifestations (1983) Schur, Phed, pp. 113-122. , The Clinical Management of SLEOrlando, Grune & Startton | |
dc.description | Wallace, D.J., Podell, T., Weiner, J., Klinenberg, J.R., Forouzesh, S., Dubois, E.L., Systemic lupus erythematosus--survival patterns. Experience with 609 patients (1981) JAMA, 245, pp. 934-938 | |
dc.description | Rothfield, N.F., (1993) SLE: Clinical aspects and treatment. Arthritis and allied conditions, pp. 1155-1177. , Philadelphia, L&F | |
dc.description | Manager, K., Manger, K., Repp, R., Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus (2002) Ann Rheum Dis, 61, pp. 1065-1070 | |
dc.description | Spiera, R.F., Homel, P., Spiera, H., Long-term outcome in lupus nephritis (2002) Ann Intern Med, 137, pp. 545-546 | |
dc.description | Beaufils, M., Kouki, F., Mignon, F., Camus, J.P., Morel-Maroger, L., Richet, G., Clinical significance of anti-Sm antibodies in systemic lupus erythematosus (1983) Am J Med, 74, pp. 201-212 | |
dc.description | Latorre, L.C., (1987) Caracterização Tecidual E Sorológica De Complexos Sm E RNP Na Nefropatia Lúpica, , São Paulo, (Dissertação Mestrado- FMUSP) | |
dc.description | Gulko, P.S., Reveille, J.D., Koopman, W.J., Burgard, S.L., Bartolucci, A.A., Alarcon, G.S., Survival impact of autoantibodies in systemic lupus erythematosus (1994) J Rheumatol, 21, pp. 224-228 | |
dc.description | Borba, E.F., Bonfa, E., Longterm beneficial effects of chloroquine diphosphate on lipoprotein profile in SLE patients with and without steroid treatment (2001) J Rheumatol, 4, pp. 780-785 | |
dc.language | pt | |
dc.publisher | | |
dc.relation | Revista Brasileira de Reumatologia | |
dc.rights | fechado | |
dc.source | Scopus | |
dc.title | Analysis Of Global Survival And Risk Factors For Death In 509 Systemic Lupus Erythematosus (sle) Patients [análise De Sobrevida Global E Fatores De Risco Para óbito Em 509 Pacientes Com Lúpus Eritematoso Sistêmico (les)] | |
dc.type | Artículos de revistas | |